Yunhong Huang

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study

Huiqiang Huang, Rong Tao, Siguo Hao et al. · Journal of Clinical Oncology · 2023 · 45 citations · Full text

Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes

Liping Gu, Jiaying Yang, Yujia Gong et al. · Journal of Diabetes · 2020 · 41 citations

Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study

Xiaoying Ding, Ying Xu, Yufan Wang et al. · Mediators of Inflammation · 2017 · 37 citations · Full text

Tsukushi and TSKU genotype in obesity and related metabolic disorders

Y Li, Jing Yan, Yunhong Huang et al. · Journal of Endocrinological Investigation · 2021 · 19 citations · Full text

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Huiqiang Huang, Rong Tao, Liqun Zou et al. · Blood · 2019 · 16 citations